Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Other Working Capital Changes of $487000.0 for Q1 2026, up 137.87% year-over-year from $204734.2 in Q1 2025, and up 151.03% quarter-over-quarter from $194000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Other Working Capital Changes for 11 consecutive years, with $487000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 137.87% year-over-year to $487000.0; the TTM figure through Mar 2026 stood at $681000.0 (up 118.37% YoY), while the FY2025 annual figure was -$1.1 million, changed N/A from the prior year.
- Other Working Capital Changes climbed to $487000.0 in Q1 2026 per RYTM's latest filing, from $194000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.2 million in Q3 2022 and bottomed at -$2.7 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$284214.3 across 5 years, with a median of -$74000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 40450.0% in 2024 and fell as far as 1807.04% in 2024.
- Rhythm Pharmaceuticals' Other Working Capital Changes stood at -$972000.0 in 2022, then sank by 180.66% to -$2.7 million in 2023, then surged by 106.63% to $181000.0 in 2024, then grew by 7.18% to $194000.0 in 2025, then surged by 151.03% to $487000.0 in 2026.
- Business Quant data shows RYTM's Other Working Capital Changes at $487000.0 in Q1 2026, $194000.0 in Q4 2025, and -$1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.80 Mn |
| Jun 30, 2026 | -2.80 Mn |
| Jun 30, 2026 | -2.80 Mn |
| Mar 31, 2026 | 487,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Mar 31, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | 181,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -2.71 Mn |